Nanomedicine and Targeted Drug Delivery: Advances and Challenges

Rukundo Sande Kibuuka

Faculty of Science and Technology Kampala International University Uganda

ABSTRACT

Nanomedicine, the application of nanotechnology to medicine, has revolutionized the field by providing novel approaches to diagnosing, treating, and preventing diseases. Among its various applications, targeted drug delivery has emerged as a key area of focus, offering the potential to enhance therapeutic efficacy and minimize side effects by directing drugs specifically to diseased cells or tissues. This review discusses the latest advancements in nanomedicine, particularly in the design and development of nanoscale drug delivery systems such as liposomes, polymeric nanoparticles, dendrimers, and inorganic nanoparticles. We explore the mechanisms of passive and active targeting, as well as stimuli-responsive delivery systems. Clinical applications in cancer therapy, cardiovascular diseases, neurological disorders, and infectious diseases are examined to illustrate the practical impact of these technologies. Furthermore, we address the challenges facing the field, including toxicity and biocompatibility concerns, manufacturing and scalability issues, regulatory and ethical considerations, and the integration of personalized medicine approaches. By providing a comprehensive overview of the current state and future directions of nanomedicine and targeted drug delivery, this review aims to highlight the transformative potential of these technologies in improving patient outcomes and advancing healthcare.

Keywords: Nanomedicine, Targeted drug delivery, Liposomes, Passive targeting, Personalized medicine

CITE AS: Rukundo Sande Kibuuka (2024). Nanomedicine and Targeted Drug Delivery: Advances and Challenges. INOSR APPLIED SCIENCES 12(3):24-28. https://doi.org/10.59298/INOSRAS/2024/12.3.2428